Usefulness of 18F-FDG-PET/CT imaging in a patient with neurosarcoidosis
Med Clin (Barc). 2018 Dec 14;151(11):464-465.
doi: 10.1016/j.medcli.2018.02.024.
Epub 2018 Apr 21.
[Article in
English,
Spanish]
Affiliations
- 1 Nuclear Medicine Department, University Hospital Marqués de Valdecilla, University of Cantabria, Molecular Imaging Group - IDIVAL, Santander, Spain. Electronic address: jjimenez@humv.es.
- 2 Department of Rheumatology, University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- 3 Nuclear Medicine Department, University Hospital Marqués de Valdecilla, University of Cantabria, Molecular Imaging Group - IDIVAL, Santander, Spain.
No abstract available
MeSH terms
-
Adult
-
Central Nervous System Diseases / diagnostic imaging*
-
Female
-
Fluorodeoxyglucose F18*
-
Humans
-
Positron Emission Tomography Computed Tomography*
-
Radiopharmaceuticals*
-
Sarcoidosis / diagnostic imaging*
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18